NAGLU and cardiac hypertrophy: Furthermore, myocardial hypertrophy, as one of the clinical manifestations of MPS IIIB, is closely related to the abnormal accumulation of lysosomes caused by NAGLU deficiency, which contributes to early mortality (De Pasquale et al., 2018).